Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Differential P-Glycoprotein/CD31 Expression as Markers of Vascular Co-Option in Primary Central Nervous System Tumors
Tiziana Annese,Mariella Errede,Antonio d’Amati,Michelina De Giorgis,Loredana Lorusso,Roberto Tamma,Domenico Ribatti +6 more
TL;DR: In this paper , the authors employed double immunohistochemical stainings for CD31, P-gp, S100A10, and mitochondria on formalin-fixed, paraffin-embedded human samples of IDH-WT glioblastoma, IDHmutant astrocytoma, and meningioma to study vascular co-option across different brain tumors and across normal, peritumoral, and intratumoral areas using the Aperio colocalization algorithm.
Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
Roberto Ronca,Emanuela Di Salle,Arianna Giacomini,Daria Leali,Patrizia Alessi,Daniela Coltrini,Cosetta Ravelli,Sara Matarazzo,Domenico Ribatti,William Vermi,Marco Presta +10 more
TL;DR: First experimental evidence about a nonredundant role of the FGF/FGFR system in the modulation of the EMT process in melanoma is presented, indicating that PTX3 or its derivatives may represent the basis for the design of novel therapeutic approaches in FGF-FGFR-dependent tumors, including melanoma.
Angiogenesis in asthma.
Domenico Ribatti,I. Puxeddu,Enrico Crivellato,Beatrice Nico,Angelo Vacca,Francesca Levi-Schaffer +5 more
TL;DR: Recent data is provided showing the contribution of allergic inflammation in increased airway vascularity and potential therapeutical approaches in asthma treatment by acting on bronchial microvascular changes.
•Journal Article
The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
TL;DR: The chick embryo chorioallantoic membrane (CAM) is commonly used as an experimental in vivo assay to study both angiogenesis and antiangiogenesis in response to tissues, cells or soluble factors as mentioned in this paper.
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
TL;DR: This review article is focused on the use of tyrosine kinase inhibitors as antiangiogenic molecules in the treatment of multiple myeloma.